Melatonin reduces oxidative damage and upregulates heat shock protein 90 expression in cryopreserved human semen

Free Radic Biol Med. 2017 Dec:113:347-354. doi: 10.1016/j.freeradbiomed.2017.10.342. Epub 2017 Oct 16.

Abstract

Sperm cells can be damaged during the semen cryopreservation process, decreasing their fertilizing ability. Physical damage and oxidative stress may occur during the freeze-thawing process. Antioxidants such as the native antioxidant melatonin can potentially improve cryopreservation outcomes. In this study, we added melatonin to cryoprotectant to examine its effect on frozen-thawed human sperm. We found that adding 0.1mM melatonin to cryoprotectant significantly increased sperm viability (24.80 ± 0.46% vs. 20.97 ± 1.27%, P < 0.05) and membrane integrity (P < 0.05), and decreased intracellular reactive oxygen species and lipid peroxidation damage. Furthermore, mRNA levels of the transcription factor NF-E2-related factor-2 and its downstream genes were significantly increased. Resistance to oxidative stress was enhanced and expression of the antiapoptotic gene Bcl-2 was increased by inclusion of 0.1mM melatonin in the cryoprotectant. Moreover, 0.1mM melatonin upregulated the expression of heat shock protein 90 (HSP90), which confers resistance to stressors in frozen-thawed sperm. Results obtained upon addition of inhibitors of melatonin receptors (luzindole and 4-P-PDOT) and an HSP90 inhibitor (geldanamycin) in the cryoprotectant demonstrated that melatonin promoted HSP90 translation via the melatonin receptor MT1 and increased adenosine triphosphate levels, thus increasing the viability of thawed sperm.

Keywords: HSP90; Human; Melatonin; Oxidative stress; Semen cryopreservation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / biosynthesis
  • Antioxidants / pharmacology*
  • Benzoquinones / pharmacology
  • Cell Survival / drug effects
  • Cryopreservation / methods*
  • Cryoprotective Agents / pharmacology
  • Gene Expression Regulation / drug effects*
  • HSP90 Heat-Shock Proteins / agonists*
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • HSP90 Heat-Shock Proteins / genetics
  • HSP90 Heat-Shock Proteins / metabolism
  • Humans
  • Lactams, Macrocyclic / pharmacology
  • Lipid Peroxidation / drug effects
  • Male
  • Melatonin / pharmacology*
  • NF-E2-Related Factor 2 / agonists
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress / drug effects
  • Protein Biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / agonists
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Receptor, Melatonin, MT1 / antagonists & inhibitors
  • Receptor, Melatonin, MT1 / genetics
  • Receptor, Melatonin, MT1 / metabolism
  • Semen / cytology
  • Semen / drug effects*
  • Semen / metabolism
  • Semen Analysis
  • Sperm Motility / drug effects
  • Tetrahydronaphthalenes / pharmacology
  • Tryptamines / pharmacology

Substances

  • 4-phenyl-2-propionamidotetraline
  • Antioxidants
  • BCL2 protein, human
  • Benzoquinones
  • Cryoprotective Agents
  • HSP90 Heat-Shock Proteins
  • Lactams, Macrocyclic
  • NF-E2-Related Factor 2
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • Receptor, Melatonin, MT1
  • Tetrahydronaphthalenes
  • Tryptamines
  • luzindole
  • Adenosine Triphosphate
  • Melatonin
  • geldanamycin